Patent · US Active

Composition comprising bortezomib

US10314880B2 · kind B2 · utility

1Cited by

0References

7Claims

0Family size

Inventors

P. Kanteepan · Sayla, IN
Sagar Laxmanbhai Vekariya · Sayla, IN
Jayanta Kumar MANDAL · Ahmedabad, IN
Sandip P. Mehta · Ahmedabad, IN

Key dates

Filing date	Aug 5, 2016
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Oct 18, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to ready to dilute injectable formulations of bortezomib comprising bortezomib, non-aqueous solvents enhancing the solubility and pH modifying agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.